VivoSim Labs (VIVS) EBT Margin Growth (5y) (2016 - 2024)
Powered by 
Analysis
VivoSim Labs (VIVS) EBT Margin Growth (5y) (2016 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -1.26 Mn |
| Sep 30, 2024 | -795,650.00 |
| Jun 30, 2024 | -762,252.00 |
| Mar 31, 2024 | -947,309.00 |
| Dec 31, 2023 | -7.13 Mn |
| Jun 30, 2023 | -430,780.00 |
| Mar 31, 2023 | -401,938.00 |
| Dec 31, 2022 | -177,925.00 |
| Sep 30, 2022 | -352,385.00 |
| Mar 31, 2022 | 117,974.00 |
| Dec 31, 2019 | 277,205.00 |
| Sep 30, 2019 | 349,092.00 |
| Jun 30, 2019 | 552,097.00 |
| Sep 30, 2018 | 662,288.00 |
| Jun 30, 2018 | 245,588.00 |
| Dec 31, 2017 | 6,601.00 |
| Sep 30, 2017 | -241.00 |
| Jun 30, 2017 | -46,150.00 |
| Mar 31, 2017 | 70,702.00 |
| Dec 31, 2016 | 315,990.00 |